水凝胶替代玻璃体:依据与策略
玻璃体切除后天然玻璃体不能再生,需合适替代物维持眼内稳态。现有气体和硅油虽助视网膜复位,但偏离天然玻璃体,可致白内障、眼压升高和乳化。本综述总结玻璃体结构与生化组成、现有替代物的挑战及水凝胶替代技术进展,重点讨论预成型与原位成型水凝胶的组成、特性和临床适用性,并展望药物递送与细胞化玻璃体替代物等未来方向。
要点
- 理想玻璃体替代物应模拟天然玻璃体的光学、力学和生化特性,并保持长期生物相容性。
- 临床现用的气体和硅油可促进视网膜复位,但可导致白内障形成、眼压升高和乳化等并发症。
- 水凝胶因与天然玻璃体相似而受关注,综述重点讨论预成型和原位成型水凝胶的组成、特性与临床适用性。
核心结论
- 水凝胶因与天然玻璃体相似而成为有潜力的玻璃体替代物,未来方向包括作为药物递送系统和结合玻璃体细胞(hyalocytes)的细胞化玻璃体替代物。
研究设计与样本
- 综述,总结玻璃体结构与生化组成、现有替代物的挑战及玻璃体替代技术进展,重点关注基于生物聚合物和合成聚合物的预成型与原位成型水凝胶。
主要发现
- 天然玻璃体不能再生,玻璃体切除后需合适替代物以维持眼内稳态。
- 临床现用的气体和硅油可促进视网膜复位,但明显偏离天然玻璃体,导致白内障形成、眼压升高和乳化等并发症。
- 预成型和原位成型水凝胶基于生物聚合物和合成聚合物,其化学组成、针对玻璃体替代物多项要求的特性及临床适用性在综述中讨论。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During vitreoretinal surgery, the vitreous body is removed and requires a suitable replacement to ensure ocular homeostasis, as the native vitreous does not regenerate. An ideal vitreous substitute should mimic the optical, mechanical, and biochemical properties of the natural vitreous while maintaining long-term biocompatibility. Currently, clinically used substitutes such as gases and silicone oils facilitate retinal reattachment but deviate significantly from the native vitreous, leading to complications such as cataract formation, increased intraocular pressure, and emulsification. Given these limitations, there is a growing interest in hydrogels as potential vitreous substitutes due to their similarity to the native vitreous. This review therefore aspires to provide a comprehensive and detailed overview of current knowledge on the structural and biochemical composition of the vitreous, the challenges associated with existing substitutes, and recent advancements in vitreous replacement technologies. Particular attention is given to preformed and in-situ forming hydrogels, based on biopolymers and synthetic polymers, discussing their chemical composition, diverse characteristics with regard to the multiple requirements for vitreous substitutes, and clinical applicability. Finally, future challenges and opportunities in developing an ideal vitreous substitute are highlighted, including vitreous substitutes as drug delivery systems as well as cellularized vitreous substitutes by combining advanced hydrogel systems with hyalocytes as vitreous cells to further replicate the versatile characteristics and functions of the native vitreous.
引用
- Schulz A, Keskar M, Swindle-Reilly KE, et al. Replacing the vitreous body with hydrogels: Rationale and strategies. Prog Retin Eye Res. 2025. PMID: 40645475. doi:10.1016/j.preteyeres.2025.101389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。